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1. Introduction 
Cancer is a disease characterized by unregulated growth of cells. This is caused by damage 
of deoxyribonucleic acid (DNA) results in mutations to vital genes that control cells 
divisions (Albert et al., 2004). The most common non-invasive approaches used for cancer 
treatment represent in chemotherapy, as well as radiotherapy. Chemotherapy uses cytotoxic 
drugs, which are also known as “anti-cancer” drugs or “anti-neoplastic.” On other hand, 
radiotherapy uses high energy of X-rays which were directed to cancerous tissues to cure or 
shrink the tumor, as well as to protect the tissue against tumor recurrence. Although 
chemotherapy and radiotherapy are capable of killing cancerous cell, nevertheless they 
cause some serious secondary effects including nausea, diarrhea, tiredness and fertility loss 
(Johannes et al., 2005).The conventional surgery of solid tumors is also an effective therapy 
for removing of well defined and accessible primary tumors located within nonvital tissue 
regions. However, this therapy is unsuitable for treatment of ill defined tumors and 
metastases, as well as tumors that embedded within vital regions (Hirsch et al., 2003). 
The current methods for cancer treatment have moderate to severe secondary effects. For 
this reason, the investigations of new alternatives are essentially. Thermo-therapy is 
considered one of the most important methods for cancer treatment. In general, the term 
thermo-therapy refers to both hyperthermia and thermal ablation therapy (Mriza et al., 2001). 
Hyperthermia therapy is based on the fact that tumor cells are more sensitive to 
temperature increase than normal tissue cells. It involves tumor heating to temperatures 
between 41- 42°C inducing almost reversible damage to cells and tissues. For thermal 
ablation therapy higher temperatures are applied ranging from 50°C to 70°C, leading to 
destruction of pathologically degenerated cells and irreversible damage resulting in 
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diminishing, disappearing of the tumors or at least growing stop. Thermal methods include 
radiofrequency ablation (RFA), focused ultrasound thermo-therapy, laser-induced thermal 
therapy and magnetic thermal ablation (Hilger et al., 2002). 
The thermal therapy can provide a minimal invasive alternative to conventional surgical 
treatment of solid tumors. In addition, the thermal therapeutic procedures are relatively 
simple to perform and therefore have the potential to improve recovery times and reduce 
the complication rates and hospital stays (Hirsch et al., 2003). Although, the thermal methods 
offer several advantages, nevertheless have some of limitations. For example, the tumor 
volume and speed of ultra-sound thermo therapy is limited by the potential destruction of 
normal tissue in the near field between the target and the ultrasound probe. Radiofrequency 
ablation and microwaves approaches suffer from common limitations that are intervening 
tissue problems. On other wards, the heating effects from these sources are non-specific. In 
addition, the energy deposition is often much slower with these moieties serving to increase 
the treatment time and generate less sharp lesion boundaries (Ko¨hrmann et al., 2002). 
To overcome these problems, new techniques in the field of nanoscience, nanotechnology 
and nanomedicine are now developing into treatment approach based on internal heating of 
tissue such as magnetic fluid hyperthermia (MFH), which in turn based on internal heating 
sources. In order to achieve the optimal effectiveness, this approach requires photo-thermal 
convectors to allow heat production within a localized region at lower incident energies. 
This requires development of particular particles that have highly magnetic properties such 
as Super-paramagnetic Iron Oxide Nanoparticles Fe3O4 (SPIO NPs). During this approach 
surrounding healthy cells are capable of surviving exposure to temperatures up to around 
46.5°C and more readily able to dissipate heat and maintain a normal temperature while the 
targeted tumor tissues have a higher thermal sensitivity than normal tissue because of 
experience difficulty in dissipating heat due to the disorganized and compact vascular 
structure (reduced blood flow), anaerobic metabolism (acidosis), and nutrient depletion. So 
an irreversible damage to diseased cells occurs at temperatures in a range from 
approximately 40°C to about 46°C (Yu-Fen et al., 2008). 
2. Nanomedicine and magnetic nanomaterials 
Nanomedicine stands at the boundaries between the physical, the chemical, biological and 
medical sciences. It originated from the imaginative idea that robots and other related 
machines at the nanometer scale could be designed, fabricated and introduced into the 
human body for repairing malignant cells at the molecular level. According to its original 
vision, nanomedicine is a process including the diagnosis, treatment and prevention of 
diseases and traumatic injuries, and the preservation and improvement of human health, 
using molecular tools and molecular knowledge of the human body (Freitas 2005). The 
progress in both nanoscience and nanotechnology makes nanomedicine practical. From a 
technical viewpoint, nanomedicine consists of the applications of particles and systems at 
the nanometer scale for the detection and treatment of diseases at the molecular level, and it 
plays an essential role in eliminating suffering and death from many fatal diseases, such as 
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cancer (Yih and Wei 2005). Based on nanofabrication and molecular self-assembly, various 
biologically functional materials and devices, such as tissue and cellular engineering 
scaffolds, molecular motors and biomolecules, can be fabricated for sensor, drug delivery 
and mechanical applications (Royal Society and Royal Academy of Engineering 2004). 
Nanomedicine has obvious advantages. First, nanoparticles are potentially invaluable tools 
for investigating cells because of their small size. Second, as their size can be controlled, 
from that of large molecules to that of small cells, the ability of nanoparticles to escape the 
vasculature in vivo can also be controlled. Third, because of their small size, nanoparticles 
can circulate systemically in the bloodstream and thus serve in roles such as magnetic 
resonance enhancement, iron delivery for the production of red blood cells and drug 
delivery to improve the availability of serum-insoluble drugs (Whitesides 2005). 
2.1. Status of nanomedicine 
Nanomedicine has developed in numerous directions, and it has been fully acknowledged 
that the capability of structuring materials at the molecular scale greatly benefits the 
research and practice of medicine. However, nanomedicine is a long-term expectation. 
Before nanomedicine can be used in clinics, fundamental mechanisms of nanomedicine 
should be fully investigated, and clinical trials and validation procedures should be strictly 
conducted. Though, it is possible that some biological entities, such as proteins, DNA and 
other bio-polymers, could be directly used for biosensor applications, nevertheless some 
serious issues, such as biocompatibility and robustness, may hinder the progress of these 
efforts. Though in many areas, such as disease diagnosis, targeted drug delivery and 
molecular imaging, clinical trials of some nanomedicine products are being made, the 
clinical applications of these techniques, which require rigorous testing and validation 
procedures, may not be realized in the near future (Royal Society and Royal Academy of 
Engineering 2004). At all events, it should be noted that although the applications of 
nanomaterials in biology and medicine are in an embryo stage, it is the great promise of 
nanomedicine that has inspired researchers to extensively investigate the interfaces between 
nanotechnology, biology and medicine (Satyanarayana, 2005). 
2.2. Magnetic nanomaterials 
The magnetic nanomaterials used in biology and medicine generally fall into three 
categories: zero dimensional nanomaterials such as nanospheres; one-dimensional 
nanomaterials such as nanowires and nanotubes; and two-dimensional nanomaterials such 
as thin films. Usually, all the nanospheres, nanorods, nanowires and nanotubes are called 
nanoparticles, among which, nanorods, nanowires and nanotubes are high aspect-ratio 
nanoparticles. In most of the biomedical applications, magnetic nanoparticles are suspended 
in appropriate carrier liquids, forming magnetic fluids, also called ferrofluids. Among the 
three types of magnetic nanoparticles, magnetic nanospheres are most widely used in 
biomedicine. To realize their biomedical applications, the magnetic nanospheres should be 
stably suspended in the carrier liquid, and they should also carry out certain biomedical 
functions. The magnetic material most often used is iron oxides, and the carrier liquids are 
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usually water, kerosene or various oils. Due to their small size, the magnetic nanoparticles 
in carrier liquids neither form sediment in the gravitational field or in moderate magnetic 
field gradients, nor do they agglomerate due to magnetic dipole interaction. However, a 
stable suspension can only be achieved if the particles are protected against agglomeration 
due to the van der Waals interaction. Usually this protection can be achieved by one 
approach is the electric charge stabilization. In this approach, a thin layer of gold is coated 
on the surface of the nanospheres. Meanwhile, the thin gold layer can also serve as an ideal 
base on which chemical or biological agents can be functionalized. These molecules generate 
a repulsive force, preventing the particles from coming into contact and thus suppressing 
the destabilizing effect of the van der Waals interaction. In practical applications, this 
approach is often used in combination for the majority of ferrofluids, since this allows the 
synthesis of suspensions which are stable over years (Could 2004).  
2.2.1. Magnetic (iron oxide nanoparticles) 
Magnetic iron oxide nanoparticles are the most investigated material in biomedical 
techniques, due to its superior biocompatibility with respect to other magnetic materials, 
either in form of oxides or pure metals. Several types of iron oxides exist in nature and can 
be prepared in the laboratory. Nowadays, only maghemite (γ-Fe2O3) and magnetite (Fe3O4) 
are able to fulfill the necessary requirements for biomedical applications. These 
requirements include sufficiently high magnetic moments, chemical stability in 
physiological conditions and low toxicity, not to mention the easy and economical synthetic 
procedures available for the preparation of these materials (Neuberger et al., 2005). 
The degree of atomic order in the iron oxide lattice, or in other words its degree of crystallinity, 
as well as the dispersity of the nanoparticles in terms of size and shape are critical parameters 
that affect their performance in diagnostic and therapeutic techniques as a contrast agent in 
magnetic resonance imaging (MRI) and hyperthermia, respectively. These parameters are 
strongly correlated to the approach for their synthesis (Maenosono et al., 2008). 
2.2.2. Synthesis of iron oxide nanoparticles 
The common existing methods to synthesize the iron oxide nanoparticles are physical, 
chemical and biological methods. Comparatively, chemical methods, especially wet 
chemical ones are much simpler and more efficient (Gupta et al., 2004). Several synthetic 
procedures have been developed to synthesize iron oxide nanoparticles. The simplest, 
cheapest and most environmentally-friendly procedure is based on the co-precipitation wet 
chemical method, which involves the simultaneous precipitation of ferrous (Fe2+) and ferric 
(Fe3+) salts in an alkaline medium (Kang, 1996). So the synthesis of iron oxide nanoparticles 
with an expected size distribution and stability of suspension is no longer the biggest 
challenge for researchers. The key issue now is how to achieve the aim of stealth of these 
nanoparticles in blood circulation and to attach them on desired sites for in vivo or in vitro 
applications (Sun, 2006). 
 
Laser and Radiofrequency Induced Hyperthermia Treatment via Gold-Coated Magnetic Nanocomposites 105 
Hydrothermal synthesis techniques are an alternative method for the preparation of highly 
crystalline iron oxide nanoparticles (Wang et al, 2005). In this case a mixture of iron salts 
dissolved in aqueous media is introduced in a sealed Teflon container and heated above the 
boiling temperature of water, and consequently the reaction pressure is increased much 
above atmospheric pressure. The synergistic effect of high temperatures and pressures 
strongly improves the quality of the nanocrystals and hence their magnetic features. 
However, and in contrast to the biological technique, there is no straightforward way to 
control the size and the shape of the final particles and usually polydisperse samples are 
obtained. 
Biological methods, since nanomaterials have comparable dimensions to biological 
aggregates, bio-related synthesis methods have been explored for novel nanoparticle 
synthesis. In biological methods, synthesis and assembly of crystalline inorganic materials 
can be regulated by biological organisms under environmentally benign conditions and 
desired chemical compositions and phases can be achieved. For example, the nucleation of 
semiconducting nanoparticles can be initiated in the presence of viruses expressing 
material-specific peptides. Other examples are the use of porous protein crystals, 
manipulation of bacteria to produce oxide nanoparticles and selection of metal-specific 
polypeptides from combinatorial libraries (Reiss et al. 2004). In biological methods, biological 
entities usually serve as templates for nanoparticles formation. In all cases, the biological 
entities were used not only to encapsulate the nanoparticles, but to strictly regulate the 
dimension of the crystals. To prepare magnetic nanoparticles, ferritin can be used which 
consists of 24 nearly identical subunits. Self-assembly of ferritin will form a spherical cage 
with a 7.5–8.0 nm-diameter cavity, which can be used for the biological storage of iron in the 
form of ferrihydrite, an iron (III) oxy-hydroxide? The protein cage is able to withstand 
relatively high temperatures for biological systems (up to 65 ◦C) and various pH values (~ 
4.0–9.0) for certain periods of time. Therefore this protein template is quite strong and will 
not cause any significant disruption of the quaternary structure. 
2.2.3. Classification of iron oxide nanoparticles 
There are many categories of iron oxide nanoparticles based on their overall diameter 
(including iron oxide core and hydrated coating). Iron oxide nanoparticles can be distinctly 
classified into super-paramagnetic iron oxide nanoparticles (SPIO NPs) between 300 nm and 
3.5 μm; standard SPIO (SSPIO) of approximately 60–150 nm; ultra small SPIO (USPIO) of 
approximately 10–40 nm (Weissleder et al., 1990); monocrystalline iron oxide nanoparticles 
(MION—a subset of USPIO) of approximately 10–30 nm and cross-linked iron oxides 
(CLIO) which is a form of MION with cross-linked dextran coating (Shen et al., 1993). 
On the other hand, the magnetic materials are characterized by the presence of magnetic 
dipoles generated by the spinning of some of their electrons. Each of these polarized 
electrons can be aligned in a parallel or antiparallel fashion with respect to the neighboring 
ones in the crystal lattice, and this type of interaction is what gives rise to the macroscopic 
magnetic effect that we can measure. Based on the magnetic response, the magnetic 
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materials can be classified into; diamagnetic, paramagnetic, ferromagnetic, ferrimagnetic, 
anti-ferromagnetic and super-paramagnetic (Cozzoli et al., 2006) as shown in Fig (1).  
Diamagnetic materials are characterized by coupled or paired magnetic dipoles, so there is 
no permanent net magnetic moment per atom. That is to say that these materials have not 
any interactions or slightly repelled with the magnetic field. The magnetic susceptibility of 
these materials is negative and independent on temperature.  
Paramagnetic materials characterized by randomly oriented (or uncoupled) magnetic 
dipoles, this can be aligned only in the presence of an external magnetic field along its 
direction. This type of material has neither coercivity nor remanence, which means that 
when the external magnetic field is switched off the internal magnetic dipoles randomize 
again. No extra energy is required to demagnetize the material and hence the initial zero net 
magnetic moment is spontaneously recovered.  
Ferromagnetic materials characterized by individual magnetic dipoles in a crystal, those can 
align parallel one to the other, hence exhibiting an enhanced collective response even in the 
absence of an external magnetic field. This is what is known as ferromagnetism. Beside strong 
intensity of magnetization, the fundamental property of ferromagnetic solids is their ability 
to record the direction of an applied magnetic field. When the magnetic field is removed, the 
magnetization does not return to zero but retains a record of the applied field.  
Ferrimagnetic and anti-ferromagnetic materials, in contrast to the ferromagnetic situation, 
neighboring magnetic dipoles can align antiparallel in the lattice, which means that they will 
cancel each other i.e. repulsion of magnetic dipoles . This type of magnetic exchange can 
lead to two different situations. The first is ferrimagnetism; when the two coupled spins show 
different values, and in that case a net magnetic dipole different than zero will still 
magnetize the material even in the absence of an external magnetic field. While the second is 
anti-ferromagnetism; when the magnetic dipoles or interacting spins have the same value and 
hence the material shows a net zero magnetization. The latter case lacks of interest for 
biomedical applications due to zero net magnetic moment arising in such materials.  
Super-paramagnetic materials, bulky sized particles of magnetic materials such as (Fe), (Co) 
or (Ni), as well as some of their alloys (FePt & FeCo) have ferromagnetic properties due to 
their multi-domain structures of the particles. In contrast, at the nanometer scale of 
approximately 14 nm, the multi-domain combined together forming a single domain crystal, 
which is classified as super -paramagnetic (Schmidt, 2001). Super-paramagnetic iron oxide 
nanoparticles are special class of paramagnetic materials which combine ferromagnetic and 
paramagnetic properties due to high magnetic moments which are observed under the 
effect of a magnetic field, but no remanent magnetic moment will be present when the 
external magnetic field is removed. This property translates into a significant advantage 
especially in vivo experiments, where the absence of coercivity or in other words the zero net 
magnetic moment of the nanoparticles after concluding the diagnostic measurement or the 
therapy will prevent the potential aggregation of the particles that could easily cause the 
formation of embolisms in the blood vessels (Thorek et al., 2006).The path of magnetization 
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M as a function of applied field H is called a hysteresis loop or M-H curve as shown in 
figure (2). 
2.2.4. Characteristics of magnetic nanomaterials for in vivo bio-applications 
When nanoparticles are used for in vivo applications, the nanoparticles have to stay with nil 
or minimal side effects. Therefore, complete characterizations of the particulate system are 
essentially to make a decision whether the use of nanocarriers systems are appropriate for 
specific in vivo applications or not. The nanoparticles can be described by the following 
physicochemical properties according to their distribution within the body system: size 
distribution, surface charge modification ,targeting, cellular uptake, bio-stability, 
metabolism, toxicity, capacity for protein adsorption, surface hydrophobicity, rate of 
loading , release kinetics, surface characteristics, density, porosity, degeneration of carrier 
system, cristallinity, density, mobility and  the molecular weight (Neubergera et al., 2005).  
2.2.4.1. Size distribution 
Most intravenous administrated nanoparticles are recognized as ‘‘foreign’’ from the body 
system and are eliminated immediately through macrophages of the mononuclear 
phagocytosis system (MPS) depending on the size. The size of particles usually refers to the 
total diameter of the particles including the core and the coating layer. It is well known that, 
the smallest diameter of capillaries in the body is 4 µm. So, NPs smaller than 4µm are taken 
up through cells of the reticuloendothelial system (RES) mainly in the liver (60–90%) and 
spleen (3–10%). While small particles up to 150 nm will be phagocytosed through liver cells. 
There is a tendency for particles larger than 200 nm to be filtered by the venous sinuses of 
the spleen, as well as will be captured and withheld in the lungs. In general, the large 
particles are eliminated faster from the blood, and have short plasma half-life-period 
compared to the small particles (Muller et al., 1997). 
2.2.4.2. Surface charge and protein adsorption 
Particles with large sizes and/or aggregations of small particles such as magnetic 
nanoparticles (MNPs) may be trapped causing emboli within the capillary bed of the lungs. 
Therefore, it is important to know the surface charge and aggregation behavior of the 
particles in the blood circulation system (Neuberger et al., 2005). 
All bare nanoparticles are unsuitable for in vivo applications, where the particle surface 
would be exposed to a biological environment and oxidized during application. Using bare 
nanoparticles directly, this could damage its structures and its properties. On the other 
hand, nanoparticles in solid phase cannot be injected into human body. So, before injection 
NPs have to be dispersed to hydrophilic solvent via specific interaction between the 
nanoparticles surface and surfactants (Harisinghani et al., 2003).  
The surface charge also plays an important role during endocytosis process. There should be 
a slower uptake for negatively charged particles due to the negative ‘‘rejection’’ effect of the 
negatively charged cell membrane. However, the endocytosis index in vitro is minimal with 
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a zeta potential close to zero. In contrast, Phagocytosis process is increased with a higher 
surface charge independent of whether the charge is negative or positive. The higher the 
surface charge the shorter is the residence time of nanoparticles in the circulatory system 
(Neuberger et al., 2005).  
The adsorption of proteins at the particle surface is called “opsonization”. This phenomenon 
results from immediate interaction between nanoparticles with plasma proteins after 
intravenous injection .The amount of adsorbed proteins is based on the size of the 
molecules, as well as the surface charge of the particle, where the capacity of protein 
adsorption increases by increasing size and charge of the particles. The adsorbed protein 
components play an important role in the biodistribution, degradation and elimination of 
the nanoparticles. Therefore, the treatment method of the nanoparticles surface must be 
addressed (Muller et al., 1997). 
The surface charge and protein adsorption capability are more related to the surfactants 
bond to the nanoparticles surface. There is another important role of surfactants on 
nanoparticles, when the NPs are injected into human body as contrast agents, these 
nanoparticles must locate the targeting area accurately and rapidly. Appropriate surfactant 
could achieve such objective. Some experiments in vitro already proved folate-mediated 
nanoparticles composed of ploy ethylene glycol (PEG) / poly ε-caprolactone have potential 
of tumor cell-selective targeting (Gee et al., 2003). 
2.2.4.3. Targeting  
All in vivo applications require that the NPs should accurately localize to therapeutic sites. 
All targeting methods could be classified to passive, active and physical targeting. The 
physical targeting is the localization of the nanoparticles with external assistance, typically 
by applied magnetic field from outside of the body; the physical targeting has less capability 
to recognize specific cells or tissues. The passive targeting based only on the disrupted 
endothelial lining of tumor tissues; enhanced penetration and retention (EPR) allows 
nanoparticles of smaller size to pass, and accumulate in the tumor. In active targeting, 
specific targeting functional groups, such as monoclonal antibodies, are immobilized on the 
particle surface to efficiently increase the chance of uptake by specific cells (Kelly et al., 2005).  
2.2.4.4. Cellular uptake 
Cellular uptake of nanoparticles is another issue that should be taken into account, when 
considering their use in diagnostic and therapeutic applications. The cellular uptake of 
nanoparticles is strongly dependent on particle size as it was proven in vitro and in vivo. In 
general, small nanoparticles can go deeper into tissue than larger particles and often 
penetrate the cell itself (Leslie-Pelecky, 2007). Lewinski et al summarized the situation for 
many types of nanoparticles (Lewinski et al., 2008). 
The cellular uptake of nanoparticles occurs through a process known as endocytosis, which 
can be generally classified into three processes depending on nanoparticles size. 
Phagocytosis process which is the predominant mechanism for uptake of large particles, 
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phagocytotic activity increases with size of particles, whereas smaller particles<150 nm can 
be up-taken by all types of cells through pinocytosis process (cell drinking).The third is non-
specific endocytosis or receptor-mediated endocytosis process (Neuberger et al., 2005).Super-
paramagnetic iron oxide nanoparticles have been shown to be uptake by a receptor 
mediated endocytosis process (Raynal et al., 2004).  
2.2.4.5. Bio-stability 
When nanoparticles are introduced into the body, several aspects can compromise its 
stability. First of all, the physiological media have different ionic strength as compared 
with the ultrapure water mainly used in laboratories: increasing the ionic strength of 
aqueous solution will suppress the electric double layer around the charged particles, 
resulting in a partial or total aggregation of the system. A similar behavior could be 
observed by the particles once they enter specific body compartments, due to a variation 
in pH with respect to the media in which the nanoparticles are initially dispersed. In 
addition, when nanoparticles are injected in the blood circulation system, a nonspecific 
adsorption of plasma proteins onto nanoparticles surface “opsonization” will occur, this 
phenomenon is more pronounced for nanometer size particles due to two main effects: 
the high surface to volume ratio, as well as the attractive forces between the nanoparticles 
such as magnetic nanoparticles. When this phenomenon occurs, a fast clearance of the 
nanoparticles is observed. To prevent such effects, several synthetic and natural polymers 
have been introduced to the nanoparticles surface including PEG and dextrin (Kohler et al., 
2004). 
2.2.4.6. Metabolism  
The metabolism process of the nanoparticles is another issue that should be taken into 
account. For example, iron oxide nanoparticles can be present in two different oxidation 
states: the ferrous Fe (II) form which will be oxidized by endogenous molecular oxygen, 
resulting in the conversion of ferrous iron to ferric Fe (III). Ferric iron is the preferred 
physiological oxidation state of iron; Fe (III) is highly reactive and can induce catalytic 
activity that may result in severe oxidative cell damage. As a result, iron carrier proteins and 
chelates are used to allow for safe transfer of iron from cell to cell within the body, and for 
safe intra-cellular storage of excess iron. The natural eventual fate of Fe3O4 nanoparticles 
above approximately 200 nm in diameter is to reside in macrophage-rich tissue, such as the 
liver and spleen (peak concentration at 2 hours after contrast intake).While particles below 
10 nm are removed rapidly through extravasations and renal clearance (Gupta et al., 2004). 
2.2.4.7. Biocompatibility 
Biocompatibility is one of the most important considerations in the development of 
biomedical applications of nanomaterials. Most of the magnetic nanowires are compatible 
with living cells. They can be functionalized with biologically active molecules, and they do 
not disrupt normal cell functions, such as cell proliferation and adhesion, and gene 
expression (Hultgren et al. 2005). 
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2.2.4.8. Toxicity  
The non-cytotoxic, non-immunogenic and biocompatible properties of nanoparticles are 
important issues for the potential application in nanoimmunology, nanomedicines and 
nanobiotechnology. When discussing the toxicity of nanoparticles, generalization becomes 
difficult because their toxicity depends on numerous factors including the dose, chemical 
composition, method of administration, size, biodegradability, solubility, pharmacokinetics, 
biodistribution, surface chemistry, design, shape and structure. In general, size, surface area, 
shape, composition and coating of nanoparticles are the most important characteristics 
regarding cytotoxicity (Neuberger et al., 2005). 
Several in vivo studies on animals had shown that, with a large dosage of 3,000 µmol Fe 
based nanoparticles per kg body weight, the histology and serologic blood tests indicated 
that no side effects occurred after 7 days of treatment (Lacava et al., 1999).  
To minimize the risks posed by nanoparticles, there are two basic avenues. One is to 
develop new highly biocompatible nonmaterials with low toxicity such as silica 
nanoparticles. Another one is the surface modification of nanoparticles with biocompatible 
chemicals such as PEG, dextrin and chitosan. Thus many great efforts are being made to 
develop nanoparticles satisfactory for biomedical applications (Cho, 2009). 
2.2.4.9. Easy detection 
As almost all biological entities are non-magnetic, magnetic nanoparticles in biological 
systems can be easily detected and traced. One typical example is the enhancement of the 
signal from magnetic resonance imaging (MRI) using magnetic nanoparticles. In this 
technique, a subject is placed in a large, external magnetic field and then exposed to a pulse 
of radio waves. Changes to the spin of the protons in water molecules are measured after 
the pulse is turned off. Tiny differences in the way that protons in different tissues behave 
can then be used to build up a 3D image of the subject (Koltsov 2004). 
2.2.4.10. Magnetic manipulation 
Magnetic nanoparticles will rotate under an external uniform magnetic field, and will make 
translational movements under an external magnetic field gradient. Therefore, magnetic 
nanoparticles, or magnetically tagged molecules, can be manipulated by applying an 
external magnetic field. This is important for transporting magnetically tagged drug 
molecules to diseased sites. The magnetic manipulation of magnetic nanowires and 
nanotubes is important for applying forces to biological entities, and for nanowires or 
nanotubes to get into biological entities. 
2.2.4.11. Energy transfer 
Magnetic nanoparticles can resonantly respond to a time-varying magnetic field, 
transferring energy from the exciting magnetic field to the nanoparticles and the tagged 
biological entities. This property has been used in hyperthermia treatment of cancer tumors 
(Pankhurst et al. 2003). 
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2.2.5. Biomedical applications of iron oxide NPs 
Nanotechnology, dealing with nanoscale objects, has been developed at three major levels: 
nanomaterials, nanodevices and nanosystems. At present, the nanomaterials level is the 
most advanced of the three. Nanomaterials are of great importance both in scientific 
investigations and commercial applications due to their size-dependent physical and 
chemical properties. Nanomaterials with various shapes have been developed successfully. 
Common morphologies are quantum dots, nanoparticles/nanocrystals, nanowires, 
nanorods, nanotubes, etc. It is desirable to have a full range within the nanomaterial family 
because many applications demand particular nanomaterials with special structures. 
Magnetic nanoparticles, being a sub-family of nanomaterials, exhibit unique magnetic 
properties in addition to other specific characteristics. Their remarkable new phenomena 
include super-paramagnetism, high saturation field, high field irreversibility, extra anisotropy, 
and temperature-depended hysteresis, etc. Research investigation has revealed that the finite 
size and surface effects of magnetic nanoparticles determine their magnetic behavior. For 
instance, a single magnetic domain forms when the size of a ferromagnetic nanoparticle is less 
than 15 nm. In other words, an ultrafine ferromagnetic nanoparticle displays a state of uniform 
magnetization under any field. Thus, at temperatures above the blocking temperature, these 
nanoparticles show identical magnetization behavior to atomic paramagnets (super-
paramagnetism) with an extremely large magnetic moment and large susceptibilities.  
Magnetic nanoparticles have found many successful industrial applications. Recently, 
tremendous research efforts have been stimulated on the usage of magnetic nanoparticles in 
the field of biomedical and biological applications. 
Understanding of biological processes and hence developing biomedical means have been 
continuously pursued. These aims are one of strong driving forces behind the development 
of nanotechnology. The interests on magnetic nanoparticles for bio-applications come from 
their comparable dimensions to biological entities coupled with their unique magnetic 
behaviors. Though common living organisms are composed of cells of about 10 µm size, the 
cell components are much smaller and generally in the nanosize dimension. Examples are 
viruses (20–450 nm), proteins (5–50 nm) and genes (2 nm wide and 10–100 nm long). 
Synthetic magnetic nanoparticles have controllable dimensions and just a few nanometer-
diameter nanoparticles can be synthesized by carefully designing experimental procedures 
and controlling experimental conditions. With such a nanoscale dimension, it would be 
possible for magnetic nanoparticles to get close to a biological entity of interest. Moreover, 
the interaction between magnetic nanoparticles and biological entities can be adjusted by 
coating nanoparticles with biological molecules, called bio-functionalization. This offers a 
controllable means of ‘tagging’ or addressing the binding at nanoscale. The comparable 
dimensions and magnetic properties of magnetic nanoparticles have prompted the idea of 
using them as very small probes to spy on the biological processes at the cellular scale 
without introducing too much interference. Actually, optical and magnetic effects have been 
treated as the most suitable approaches for biological applications owing to their non-
invasive behavior. 
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In view of the magnetic properties of magnetic nanoparticles, they can be manipulated by 
an external magnetic field gradient, which is described by Coulomb’s law. Magnetic 
nanoparticles are able to transport into human tissues due to the intrinsic penetrability of 
magnetic fields into human bodies. This ‘action at a distance’ opens up many potential bio-
applications including transportation of magnetically tagged biological entities, targeted 
drug delivery, etc. Another important property of magnetic nanoparticles is their resonant 
response related to a time-varying magnetic field (Pankhurst et al. 2003). Hence energy 
transfer from the exciting field to the magnetic nanoparticles can be realized. In this way, 
toxic amounts of thermal energy are able to be delivered via magnetic nanoparticles to the 
targeted tumors resulting in malignant cell destruction. This process is named 
hyperthermia, which will be addressed in detail in this chapter. In addition to the site-
specific drug delivery and hyperthermic treatment, magnetic nanoparticles have found 
other versatile bio-applications such as magnetic bio-separation, contrast enhancement of 
magnetic resonance imaging, gene therapy, enzyme immobilization, magnetic manipulation 
of cell membranes, immunoassays, magnetic bio-sensing, etc. (Sun et al. 2005). Each 
application depends upon the relationship between the external magnetic field and the 
biological system. Magnetic fields with proper field strength are not deleterious to either 
biological tissues or biotic environments. In a given bio-application, magnetic nanoparticles 
are usually injected intravenously into the human body and are transported to the targeted 
region via blood circulation for biomedical diagnostic or treatment. An alternative means is 
using magnetic nanoparticle suspension for injection (Berry 2003). It has been well accepted 
that a desirable magnetic medium should not contain nanoparticle aggregation, which will 
block its own spread. For this reason, stable, uniform magnetic nanoparticle dispersion in 
either an aqueous or organic solvent at neutral pH and physiological salinity is required. 
The stability of this magnetic colloidal suspension depends on two parameters: an ultra 
small dimension and surface chemistry. The particle size should be sufficiently small to 
avoid precipitation due to gravitation forces while the charge and surface groups should 
create both steric and coulombic repulsions which stabilize the colloidal suspensions. 
The magnetic properties of magnetic nanoparticles are determined by their elemental 
compositions, crystallinity, shapes and dimensions. Various magnetic nanoparticles have 
been developed. Therefore, the selection of proper magnetic nanoparticles with the desired 
properties is the first but crucial step for certain bio-applications. For example, 
ferromagnetic nanoparticles (e.g. Fe nanoparticles) have a large magnetic moment and they 
can be the best material candidate in magnetic biosensors because they not only produce a 
better signal but respond to an applied magnetic field readily. On the other hand, iron oxide 
nanoparticles with super-paramagnetic behavior do an excellent job when used to enhance 
the signals in magnetic resonance imaging examinations. With the help of iron oxide 
nanoparticles a sharpened image with detailed information can be achieved because of the 
change of behavior of nearby bio-molecules by introduced nanoparticles (Bystrzejewski et al. 
2005). For many biomedical applications, magnetic nanoparticles presenting super-
paramagnetic behavior (no remanence along with a rapidly changing magnetic state) at 
room temperature are desirable. Biomedical applications are commonly divided into two 
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major categories: in vivo and in vitro applications. Consequently, additional restrictions 
apply on various magnetic nanoparticles for in vivo or in vitro biomedical applications. It is 
rather simple for in vitro applications of magnetic nanoparticles. The size restriction as well 
as biocompatibility/toxicity is not so critical for in vitro applications, when compared with in 
vivo ones. Therefore, super-paramagnetic composites containing submicron diamagnetic 
matrixes and super-paramagnetic nanocrystals can be used. Composites with long 
sedimentation times in the absence of a magnetic field are also acceptable. It was noticed 
that functionalities may be provided readily for the super-paramagnetic composites because 
of the diamagnetic matrixes (Tartaj et al. 2003). On the other hand, severe restrictions must 
be applied for magnetic nanoparticles for in vivo biomedical applications. First of all, it is a 
requisite that the magnetic components should be biocompatible without any toxicity for the 
bio-systems of interest. This is predominantly determined by the nature of the material (e.g. 
iron, nickel, cobalt, metal alloy, etc). For instance, cobalt and nickel are highly magnetic 
materials. However, both of them are rarely used due to their toxic properties and 
susceptibility to oxidation. Currently, the most commonly employed magnetic nanoparticles 
in biomedical applications are iron oxides including magnetite (Fe3O4), maghemite (γ -
Fe2O3) and hematite (α-Fe2O3). The second requirement for magnetic nanoparticles is their 
particle sizes. Ultrafine nanoparticles (usually smaller than 100 nm in diameter) have high 
effective surface area, thus they can be attached to ligand easily. Also the lower 
sedimentation rate leads to a high stability for colloidal suspensions, and the tissue diffusion 
can be improved by using nanoparticles in nanometer dimensions. After injection, 
nanoparticles would be able to remain in the circulation and pass through the capillary 
systems to reach the targeted organs and tissues without any vessel embolism. Further, the 
magnetic dipole–dipole interaction among magnetic nanoparticles can be substantially 
reduced. The third requisite for magnetic nanoparticles is their biocompatible polymer 
coating which may be done during or after the nanoparticle synthesis. There are several 
functions of the coating layers: 1) they will prohibit agglomeration of nanoparticles; 2) they 
prevent structural or elemental changes; 3) unnecessary biodegradation can be stopped; 4) 
the polymer layer offers a covalent binding or adsorption attachment of drugs to the 
nanoparticle surface. In summary, for in vivo biomedical applications, magnetic 
nanoparticles must be made of a non-toxic and non-immunogenic material with ultra small 
particle sizes and high magnetization. 
It is no doubt that interdisciplinary research collaboration is badly needed for clinical and 
biological applications of magnetic nanoparticles (Berry 2003). Research fields involved 
include chemistry, materials science, cell engineering, clinical tests and other related 
scientific efforts. In this chapter, an overview of cancer treatment approach as one of 
biomedical applications of magnetic nanoparticles will be presented 
3. Hyperthermia treatment 
Another major use of magnetic nanoparticles in therapeutic treatment is hyperthermia 
treatment for cancers. Gilchrist et al. did the experimental investigations for the first time 
when they heated various tissue samples with γ - Fe2O3 of 20–100 nm in diameter by a 
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1.2MHz magnetic field (Gilchrist et al. 1957). Since then, studies have shown the feasibility of 
using the hyperthermic effect generated from magnetic nanoparticles by applying a high-
frequency AC magnetic field as an alternate therapeutic approach for cancer treatment. 
Briefly speaking, the hyperthermic effect is generated from the relaxation of magnetic 
energy of the magnetic nanoparticles which is able to destroy tumor cells effectively (Levy et 
al. 2002). Hyperthermia is a common cancer therapy in which certain organs or tissues are 
heated preferentially to temperatures between 41 ◦C and 46 ◦C, artificially induced 
hyperthermia has been designed to heat malignant cells without destroying the surrounding 
healthy tissue. When heated to a higher temperature (~56 ◦C), coagulation or carbonization 
may occur. This ‘thermo-ablation’ induces a completely different biological response and 
hence is not considered as hyperthermia. A classical hyperthermia not only causes almost 
reversible damage to cells and tissues, but also enhances radiation injury of tumor cells 
(Jordan et al. 1999). For modern clinical hyperthermia trials, moderate temperatures (42–43 
◦C) are normally selected to optimize the thermal homogeneity in the target area. It is true 
that the heating effect will change the dose-dependent behavior of treated cells. However, 
the exact mechanism of thermal dose-response in hyperthermia is still unknown. There are 
great difficulties in identifying the individual cell as the target for hyperthermia. Instead, 
hyperthermia affects most bio-molecules including proteins and receptor molecules. On the 
other hand, DNA damage by irradiation has been well understood due to the highly specific 
interaction. As far as the underlying physics of the heating effect in hyperthermia is 
concerned, magnetic heating via magnetic nanoparticles essentially is determined by their 
sizes and magnetic properties (Mornet et al. 2004). 
Magnetic nanoparticles can be divided into two major categories: multi-domain and single-
domain nanoparticles, which possess different heating effects. Multi-domain nanoparticles 
usually have larger dimensions and contain several sub-domains with definite 
magnetization direction for each. When they are exposed to a magnetic field, a phenomenon 
called ‘domain wall displacements’ occurs. This is featured by growth of the domain with 
magnetization direction along the magnetic field axis and shrinkage of the other. Figure 2 
above, depicts this irreversible phenomenon. It can be seen that the magnetization curves for 
increasing and decreasing magnetic field do not coincide, and the area within the hysteresis 
loop represents the heating energy, named ‘hysteresis loss’, due to the AC magnetic field. 
For single-domain nanoparticles, since there is no domain wall, no hysteresis loss occurs 
leading to no heating. When exposed to an external AC magnetic field, rotation of magnetic 
moments from super-paramagnetic nanoparticles is assisted by the supplied energy which 
overcomes the energy barrier. Then these nanoparticles undergo N´eel relaxation in which 
their moments relax to their equilibrium orientation. Simultaneously, heat is generated 
during this relaxation by thermal dissipation. The N´eel relaxation time tN is related to the 
temperature, and can be described as: 
 tN = t0e KV/kT (1)    
Where t0 ≈ 10−9 s, T is the temperature and k is the Boltzmann constant. For both multi- and 
single-domain nanoparticles, rotational Brownian motion in a carrier also generates heat. 
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This rotation is caused by the torque exerted on the magnetic moment by the AC magnetic 
field. The Brown relaxation time tB is described as: 
 tB = 3ηvB/kT  (2) 
Where η is the viscosity of the carrier, and vB is the frequency for maximal heating via 
Brown rotation, corresponding to the hydrodynamic volume of the particle, and it is given 
by the equation 2πvBtB = 1. 
The heating capacity of magnetic nanoparticles is expressed by specific absorption rate SAR, 
also called specific power loss (SPL), both of them have the same physical meaning, which 
determines the heating ability of magnetic nanoparticles in the presence of magnetic field, 
and can be defined as the amount of heat generated per unit gram per unit time. SAR values 
are usually expressed in watts per gram of magnetic material (W/g), also can be expressed in 
volumetric units (W/m3).The heat generated per unit volume can be obtained by multiplying 
the SAR value by the density of the nanoparticles. It has been well documented that the 
orientation and magnetized domains of magnetic nanoparticles are dependent on their 
intrinsic features (elemental composition, crystallinity, magneto anisotropy, shape, 
dimension, etc.) and micro-structural features (impurities, grain boundaries, vacancies, etc). 
In magnetic hyperthermia treatment, after heat conducts into the area with diseased tissues, 
the surrounding temperature can be maintained above the therapeutic threshold of 42 ◦C for 
about half an hour to destroy the cancer. It is of great importance for hyperthermia to 
minimize the heat effect on healthy cells. Assisted by magnetic nanoparticles, it is possible to 
heat the specific area while unacceptable coincidental heating of healthy tissue is avoided. 
Although the hyperthermia treatment for cancer has been demonstrated with therapeutic 
efficacy in animal models, however, there have been no reports of successful hyperthermia 
treatment for human patients. The major reasons are the necessities of an adequate amount 
of magnetic nanoparticles and sufficiently high magnetic field which are not safe for human 
treatments. To date, laboratory research efforts on hyperthermia treatment for animals have 
all used magnetic field conditions which are not clinically acceptable. In most instances, 
hyperthermia treatments with a reduced amount of magnetic nanoparticles and reduced 
field strength or frequency cannot be effective due to the reduction of heat generated. 
Simulations suggest a sufficient level with heat deposition rate of 100mWcm−3 to destroy 
cancer cells effectively in most circumstances. The practical frequency and strength of the 
external AC magnetic field are 0.05–1.2MHz and 0–15 kAm−1, respectively. On the other 
hand, sufficient magnetic materials are needed to enrich around the cancer tissues to 
generate enough heat for hyperthermia treatment. Direct injection of ferrofluid into the 
tumor tissues is able to introduce a large amount of magnetic materials for heat generation. 
Antibody targeting and intravascular administration offer better preference heating, but the 
problem here is the small quantity. It is estimated that about 5–10 mg of magnetic material 
concentrated in each cm3 of tumor tissues is able to generate enough heat for tumor cell 
destruction in human bodies. Magnetite (Fe3O4) and maghemite (γ -Fe2O3) nanoparticles are 
two common types used in hyperthermia treatments owing to their appropriate magnetic 
properties and their excellent biocompatibilities. Several examples will be given here. 
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The history of using magnetic particles for selective heating of the tumors started in 1957 
when Gilchrist et al used particles of a few mm in size for inductive heating of lymph nodes 
in dogs (Gilchrist et al., 1957). More than 20 years later, Gordon et al used a magnetic fluid 
(‘dextran-magnetites’ with a core size of up to ~ 6 nm) for inducing hyperthermia (Jordon et 
al., 1979). Injection of micro-scaled ferromagnetic particles into renal carcinomas of rabbits 
and subsequent heating was reported by Rand and co-workers (Rand et al., 1981). Magnetic 
nanoparticles used in a different approach termed as ferromagnetic embolization. In this 
technique, the MNPs were injected into the main feeding artery of the tumor; this injection 
resulted in aggregates of MNPs which in turn embolized the feeding artery and hence 
necrosis of the tumor cells. This technique seems to be especially well suited for the 
treatment of hepatic malignancies due to the differences in blood supply between hepatic 
tumor cells and normal liver parenchyma (Archer et al., 1990). Direct injection of dextran-
coated magnetite NPs with a core size of ~ 3 nm into tumors was first reported in 1997 
(Jordan et al., 1997). Other groups in Japan developed “magnetic cationic liposomes” (MCLs) 
with improved adsorption and accumulation properties within tumors and demonstrated 
the efficacy of their technique in several animal tumor models: rat glioma (Le et al., 2001). 
Hilger et al injected colloidal suspensions of coated MNPs (particle sizes of ~10 nm and 200 
nm) into human carcinomas implanted into mice (Hilger et al., 2002). Ohno et al inserted 
stick-type carboxymethyl cellulose magnetite containing NPs into gliomas and described as 
a three-fold prolongation of survival time (Ohno et al., 2002). Moroz and co-workers 
concluded from their data that for a given tumor iron concentration, larger tumors heat at a 
greater rate than small tumors due to the poorer tissue cooling and better heat conduction in 
the necrotic regions of large tumors (Moroz et al., 2002). Tanaka et al used MCLs in 
melanoma in combination with immunotherapy (Tanaka et al., 2005) and used for prostate 
cancer treatment (Kawai et al., 2005). Yan et al. demonstrated the use of Fe2O3 nanoparticles 
combined with magnetic fluid for hyperthermia treatment on human hepatocarcinoma 
SMMC-7721 cells in vitro and xenograft liver cancer in nude mice (2005). Their experiments 
verified the significantly inhibitory effect of magnetic ferrofluid in weight and volume on 
xenograft liver cancer. After infiltrating magnetic ferrofluid into the target tissues, a time-
varied magnetic field was applied and its energy was transformed to heat energy by the 
magnetic nanoparticles resulting in a temperature rise to 42–45 ◦C. This generated heat is 
able to kill malignant tumor cells without injuring the normal cells nearby. The growth and 
apoptosis of SMMC-7721 cells treated with the ferrofluids containing Fe2O3 nanoparticles at 
various concentrations (2, 4, 6 and 8 mg/ml) were examined by MTT, flow cytometry (FCM) 
and transmission electron microscopy (TEM) after 30–60 minute treatments. It was observed 
that Fe2O3 nanoparticles-based ferrofluid could significantly inhibit the proliferation and 
increase the ratio of apoptosis of SMMC-7721 cells. These dose-dependent inhibitions were 
26.5 %, 33.53 %, 54.4 %, 81.2 %, and 30.26 %, 38.65 %, 50.28 %, 69.33 %, for inhibitory rate 
and apoptosis rate, respectively. It was also observed from animal experiments that the 
tumors became smaller and smaller as the dosage of magnetic ferrofluid increased. The 
weight and volume inhibitory ratios were 42.10 %, 66.34 %, 78.5 %, 91.46 %, and 58.77 %, 
80.44 %, 93.40 %, 98.30 %, respectively. In a comparison of the control and experimental 
groups, each group exhibited significant difference. According to histological examination, 
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many brown uniform spots are located at the stroma in the margin of the tumors, which are 
identified as iron oxide nanoparticles. Although interstitial hyperthermia following direct 
injection of nanoparticles has been proven successful in many animal models, nevertheless 
only one of these approaches has been successfully translated from research to clinical stage 
for prostate cancer treatment either by iron oxide against RF ,this clinical studies were 
performed by Johannsen 2005. 
Fumiko et al 2004 developed magnetite cationic liposomes (MCLs) and applied them to local 
hyperthermia as a mediator. MCLs have a positive charge and generate heat under an 
alternating magnetic field (AMF) by hysteresis loss. In this study, the effect of hyperthermia 
using MCLs was examined in an in vivo study of hamster osteosarcoma. In this study, three-
week-old Syrian female hamsters were purchased from Japan SLC, Inc., Shizuoka, Japan, 
and used for the animal study. After that MCLs were injected into the osteosarcoma and 
then subjected to an AMF. The results revealed that, the tumor was heated at over 42°C, but 
other normal tissues were not heated as much. Complete regression was observed in 100% 
of the treated group hamsters, whereas no regression was observed in the control group 
hamsters. At day 12, the average tumor volume of the treated hamsters was about 1/1000 of 
that of the control hamsters. In the treated hamsters, no regrowth of osteosarcomas was 
observed over a period of 3 months after the complete regression. These results suggest that 
this treatment is effective for osteosarcoma. 
One of recent and novel study was applied by El Sherbini et al (2011). The aim of this 
experimental study is to evaluate the effect of magnetic resonance on magnetic 
nanoparticles, this in -vivo experiments in which hyperthermia is induced in female Swiss 
albino mice weighing 20.0 to 29.2g median, 26.3g  implanted with subcutaneous Ehrlich 
carcinoma cells under magnetic resonance imaging. The strategy of this study was based on 
preparation, characterization of super-paramagnetic magnetic iron oxides nanoparticles and 
evaluation of magnetic resonance hyperthermia (MRH) technique in presence of super-
paramagnetic nanoparticles and an alternating magnetic field (AMF). 
Preparation of tumors bearing mice and iron oxide magnetic nanoparticles followed the 
method described by Elsherbini et al (2011). The prepared SPIO nanoparticles were 
suspended in glycerin medium to increase the stability especially in vivo conditions. The 
prepared suspension was stable for several months due to the high viscosity of glycerin. The 
influence of the SPIO nanoparticles concentration on the total amount of specific heat energy 
dose (SED) was studied in a preliminary study. The mean values of the total cumulative 
specific energy dose were monitored for different concentrations of SPIO nanoparticles in 
the tumors. The mean values reported of SED Jgm-1 were [282.1±13.8 for (200µg), 462.7±10.0 
for (400µg), 663.7±13.0 for (600µg), 864.1±16.6 for (800µg) and 1087 ±18 for (103µg)] as shown 
in figure (3). The quantitative analysis revealed that, the SED values were directly 
proportional to the concentrations of the injected nanoparticles inside the tumors.  
The results of heat deposition rate HDR inside the tumor revealed that, the mean values of 
HDR were [0.157 for (200µg), 0.259 for (400µg), and 0.367 for (600µg), 0.478 for (800µg) and 
0.604 for (103µg)] as shown in figure (4). These values varied considerably between the 
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different concentrations of SPIO nanoparticles with highly significant p value p <.007. The 
temperature changes were recorded in the intra-tumoural SPIO nanoparticles accumulation. 
The results revealed that the maximum temperatures achieved were [40.11±1.52°C for 
(200µg), 42.36±1.54°C for (400µg), 44.43±2.0°C for (600µg), 46.8±1.5°C for (800µg) and 
48.6±1.0 °C for (103µg)] as shown in figure (5).The time taken to maximum temperature TMT 
was recorded as [40±2.5 min for 200&400µg, 30±2.0 min for 600µg, 25±5.0 min for 800µg and 
20± 5.0 min for 103µg] as shown in figure (6). The statistical analysis revealed that the TMT 
values were inversely proportional to the concentrations of the injected nanoparticles inside 
the tumors. In vivo experiments for magnetic resonance hyperthermia demonstrated that the 
use of SPIO nanoparticles combined with magnetic resonance for hyperthermia treatment 
on Ehrlich carcinoma. The experiments revealed that after treatment sessions, magnetic 
resonance images verified degree of apoptotic cells presented by dark signal intensity in the 
center of the tumor in all mice on T1 weighted images; the centers of the lesions were 
asymmetrical and non-homogenous when compared to magnetic resonance images before 
treatment, as well as the images showed variations in signal intensity in the abdominal 
regions attributed to the distribution of the SPIO nanoparticles over the treatment sessions 
as shown in figure (7). As well as the experiments verified the significantly inhibitory effect 
of SPIO nanoparticles in volume on Ehrlich tumor. Significant volume differences between 
mice in all groups under experiments are shown in figure (8). It worth mentioning that, 
histopathology examination was further used to confirm MR results. 
Plasmonic photo-thermal therapy (PPTT).Gold nanoshells belong to a prospective class of 
optical adjustable nanoparticles with a dielectric silica core encased in a thin metallic gold 
shell (Hirsch, et al 2006). The absorption cross-section of a solid nanoshell is high enough to 
provide a competitive nanoparticle technology with application of indocyanine green dye, a 
typical photothermal sensitizer used in laser cancer therapy (Gupta, et al 2007).  
On the other hand, there are several in vitro experiments concerning application of gold 
nanoparticles and core shell NPs to PPTT of cancer cells, while number of in vivo studies is 
quite limited (Loo, et al, 2005). The first account of the use of gold nanoparticles in hyper-
thermal therapy was published in 2003. Halas et al used gold -on-silica nanoshells to treat 
breast carcinoma cells using the HER2 antibody (Hirsch et al., 2003). Another study using 
pulsed laser and gold nanospheres was performed in 2003 by Lin and co-workers for 
selective and highly localized photothermolysis of targeted lymphocytes cells. Lymphocytes 
incubated with gold nanospheres conjugated to anti-bodies were exposed to nanosecond 
laser pulses (Q-switched Nd: YAG laser, 565 nm wavelength, 20 ns duration) .The results 
showed that 100 laser pulses at an energy of 0.5 J/cm2 were sufficient to induce cell death. 
While adjacent cells just a few micrometers away without nanoparticles remained viable 
(Pitsillides et al., 2003). In the same year, Zharov et al performed similar studies on the photo-
thermal destruction of K562 cancer cells. They further detected the laser induced- bubbles 
and studied their dynamics during the treatment using a pump–probe photo thermal 
imaging technique (Zharov et al., 2003). O’Neal et al 2004 reported in vivo impressive results 
by showing selective photo-thermal ablation in mice using near infrared-absorbing NPs (O, 
Neal et al., 2004). Another in vivo study was applied on a murine model using NIR light against 
gold nanoshells (Loo et al., 2004). 
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In a study by El- Sayed and co-workers conjugated gold nanoparticles of approximately 40 
nm to anti-epithelial growth factors receptors (EGFR) antibodies and targeted to types of 
human head and neck cancer cells, the nanoparticles induce cancer cell damage at 19 W/cm2 
after the irradiation with argon Ar+ laser at 514 nm for 4 min, while healthy cells do not 
show the loss of cell viability under the same treatment (El Sayed et al., 2005). 
Huang et al also described the photo-thermal destruction of cancer cells using bio-
functionalized gold nanorods. The nanorods were conjugated to anti- EGFR (specific 
antibody to the malignant cell types used), and then incubated with a non-malignant 
epithelial cell line (HaCat), as well as two malignant oral epithelial cell lines (HOC313 
clone8 and HSC3). Following laser irradiation, the results revealed that the malignant cells 
were destroyed at about half the laser fluence needed to kill the nonmalignant cells. The 
efficient destruction of the malignant cells was evidently due to the preferential attachment 
of the anti-EGFR-gold nanorod conjugates to the over-expressed EGFR on the surface of the 
malignant cell (Huang et al., 2006). 
In 2006, El-Sayed and co-workers conjugated gold nanorods to anti-EGFR antibodies 
specifically bind to the head and neck cancer cells, these labeled cells subjected to laser 
irradiation (Ti: Sapphire laser, CW at 800 nm) which was maximally overlapped with the 
surface plasmonic resonance absorption band of the nanorods. Under laser exposure for 4 
min, it was found that the cancer cells required half the laser energy (10 W/cm2) to be photo- 
thermally damaged as compared to the normal cells (20 W/cm2) (El Sayed et al., 2006). 
In 2007, Huff and co-workers conjugated folate ligands with oligo-ethylene-glycol onto gold 
nanorods by in situ dithio-carbamate formation; the folate conjugated gold nanorods were 
selectively bound to KB cancer cells (a tumor cell line derived from oral epithelium) which 
led to photo-thermal damage on cell membranes following laser irradiation (Huff et al., 
2007). Another study from the same group showed that under laser irradiation membrane 
blebbing occurred due to the influx of calcium ion Ca2+ into the cells (Tong et al., 2007). 
Attempts using gold nanocages for PPPT have also been made recently. In the in vitro 
studies by Li and co-workers conjugated gold nanocages of approximately 30 nm to anti-
EGFR to target A431 cells. At laser energy density of 40 W/cm2, almost all immunonanocage 
treated cells were damaged (Li et al., 2008). Other in vitro studies by Xiaohug and co-workers 
using gold nanocages of approximately 45 nm conjugated to HER-2 and near infrared 
femtosecond Ti: Sapphire pulsed laser to treat Sk-BR-3 breast cancer cells (Xiaohua et al., 
2010).  
Paul and Tuan reported the application of liposome-encapsulated gold nanoshells for in 
vitro photo-induced hyperthermia in human mammary carcinoma cells. In addition to 
evaluating their effects in vitro, the authors compared the application liposome-
encapsulated gold nanoshells and free-standing gold nanoshells for NanoPhotoTherapy 
(NPT). NPT-induced hyperthermia was performed using a 785-nm near-infrared light from 
a diode laser and the in vitro effects were evaluated using nucleic acid molecular probes by 
fluorescence microscopy. Additionally, they monitored the effectiveness of NPT by 
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detecting apoptosis via capase-9 activity. The experiments clearly showed that liposomal 
delivery enhanced the intracellular bioavailability of gold nanoshells and thus is able to 
induce a higher degree of cell death more effectively than free-standing gold nanoshells. 
Single-walled carbon nanotubes (SWNTs) have a high optical absorbance in the near-
infrared (NIR) region. In this special optical window, biological systems are known to be 
highly transparent. The optical properties of SWNTs provide an opportunity for selective 
photo thermal therapy for cancer treatment. Specifically, SWNTs with a uniform size about 
(0.81 nm) and a narrow absorption peak at 980 nm are ideal candidates for such a novel 
approach. In a study by Feifan et al, SWNTs are conjugated to folate, which can bind 
specifically to the surface of the folate receptor tumor markers. Folate- SWNT (FA-SWNT) 
targeted tumor cells were irradiated by a 980 nm laser. Results in vitro and in vivo 
experiments revealed that FA-SWNT effectively enhanced the photo thermal destruction on 
tumor cells and noticeably spared the photo thermal destruction for non targeted normal 
cells. Thus, SWNTs, combined with suitable tumor markers, can be used as novel 
nanomaterials for selective photo thermal therapy for cancer treatment. The authors used 
the mammary tumor model with EMT6 cells in the female Balb/c mice to investigate the in 
vivo effects of FA-SWNT. The mouse tumors with or without FA-SWNT were treated by the 
980-nm laser. To determine the effects of NIR optical excitation of SWNTs inside tumors, the 
authors measured the temperature on the tumor surface during the irradiation by the 980-
nm laser with an infrared thermal camera. In one experimental mouse, irradiation of tumors 
with a power density of 1 W/cm2 with FA-SWNT (1 mg/kg) for 5 min caused a surface 
temperature elevation of 63 °C. Without FASWNT, the tumor irradiated at the same light 
dose caused a surface temperature elevation of 54 °C. Experiments with other animals 
yielded similar results. These findings clearly show that FA-SWNT could effectively 
enhance the tumor photo thermal therapy. 
Kim et al achieved close to 90% cancer cell destruction in vitro using FeNi@Aumagnetic-
vortex microdiscs (MDs), on the application of only a few tens of hertz AMF for just 10min. 
This confirms that operation of MFH at lower frequencies is possible and for effective heat 
generation can be achieved using core–shell type of structures. Likewise, in yet another 
demonstration, a gold coating of approximately 0.4 to 0.5 nm thickness around SPIONs 
resulted in a four- to five-fold increase in the amount of heat released (the highest value of 
976W/g in ethanol at 430 Hz frequency) in comparison with SPIONs on application of low 
frequency oscillating magnetic fields (44–430 Hz). This study was done by Mohamed et al 
2010. In addition, the SPIONs@Au were found to be not particularly cytotoxic to 
mammalian cells. (MCF-7 breast carcinoma cells and H9c2 cardiomyoblasts) in in vitro 
studies were done by Pollert et al 2010. When similar heating experiments were carried out 
using stable water suspensions of La0.75Sr0.25MnO3 cores covered by silica (conc. of 
Mn=3.39 mg/ml), highest SAR of 130 W/g Mn at 37 °C was reached for the applied 
amplitude and frequency of 8.7 kAm−1, 480 kHz respectively. 
In this context, a study was done by Elsherbini and co-workers, 2011. The group evaluated 
two different approaches in the nanotechnology era for inducing hyperthermia in 
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subcutaneous Ehrlich carcinoma cells. The first called Optical Resonance Hyperthermia 
(ORH) technique in presence of gold nanospheres and green diode laser, as shown in fig (9). 
While the second technique called Magneto-Optical Resonance Hyperthermia (MORH), in 
presence of gold-iron oxide core shell nanoparticles with green, near infra-red diode laser, 
and magnetic field, as shown in fig (10). This approach was performed under magnetic 
resonance imaging guidance. The results revealed that, all mice treated by the first 
technique, the tumors were still as the same as before the treatments, as well as the rate of 
tumors growth were very slow if compared with the control mice. In contrast more than 
50% of the mice treated with the second technique revealed a complete disappearance of the 
tumor, as shown in figure (11). So the study have demonstrated that a pair of synthetic 
nanospheres can work together more effectively for inducing hyperthermia than individual 
nanospheres, whereby more than .So, this simple, non-invasive method shows great 
promise as a treatment technique for clinical setting. 
There are two main advantages of the plasmonic photothermal therapy technique. Firstly, 
there is the benefit of photostability compared with the photosensitizer dyes used in 
photodynamic therapy, which suffer from photobleaching as well as diffusion under laser 
irradiation. Secondly, there is the advantage of absorption and scattering cross-sections of 
gold nanoparticles, which are significantly superior to the absorbing dyes conventionally 
used in biological systems. Mie theory estimates that the optical cross-sections of gold 
nanospheres are typically four to five orders of magnitude higher than those of conventional 
dyes.  
In spite of much progress having been made using the plasmonic photothermal therapy 
technique for cancer treatment in a laboratory setting, there are still many factors which 
must be taken into account before this method may be taken to a clinical setting, and they 
need to be studied further. First of all, the distribution of the elevated temperature under 
plasmonic photothermal therapy treatment is related to absorption of light by nanospheres 
acting as point wise local heat sources and by thermal diffusion over surrounding tissues. At 
the practical level, plasmonic photothermal therapy needs to provide an appropriate 
temperature increment, ΔT, gold nanosphere concentration, laser power density, duration of 
laser exposure, optimization of absorption and scattering cross-sections of nanospheres, as 
well as penetration of the laser light into the area of interest. It should be noted that the 
biological effects have a nonlinear dependence on changes in particle concentration and 
laser power density, which is defined by the type of tissue and thermoregulation ability of 
the living organism. 
Although interstitial hyperthermia following direct injection of nanoparticles has been 
proven successful in many animal models, nevertheless only one of these approaches has 
been successfully translated from research to clinical stage for prostate cancer treatment 
either by iron oxide against RF ,this clinical studies were performed by Johannsen 2005. The 
aim of this pilot study was to evaluate whether the technique of magnetic fluid 
hyperthermia can be used for minimally invasive treatment of prostate cancer. This paper 
presents the first clinical application of interstitial hyperthermia using magnetic 
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nanoparticles in locally recurrent prostate cancer. Treatment planning was carried out using 
computerized tomography (CT) of the prostate. Based on the individual anatomy of the 
prostate and the estimated specific absorption rate (SAR) of magnetic fluids in prostatic 
tissue, the number and position of magnetic fluid depots required for sufficient heat 
deposition was calculated while rectum and urethra were spared. Nanoparticle suspensions 
were injected transperineally into the prostate under transrectal ultrasound and flouroscopy 
guidance. Treatments were delivered in the first magnetic field applicator for use in 
humans, using an alternating current magnetic field with a frequency of 100 kHz and 
variable field strength (0–18 kAm-1). Invasive thermometry of the prostate was carried out in 
the first and last of six weekly hyperthermia sessions of 60 min duration. CT-scans of the 
prostate were repeated following the first and last hyperthermia treatment to document 
magnetic nanoparticle distribution and the position of the thermometry probes in the 
prostate. Nanoparticles were retained in the prostate during the treatment interval of 6 
weeks. Using appropriate software (AMIRA), a non-invasive estimation of temperature 
values in the prostate, based on intra-tumoural distribution of magnetic nanoparticles, can 
be performed and correlated with invasively measured intra-prostatic temperatures. Using a 
specially designed cooling device, treatment was well tolerated without anesthesia. In the 
first patient treated, maximum and minimum intraprostatic temperatures measured at field 
strength of 4.0–5.0 kAm-1 were 48.50C and 40.00C during the 1st treatment and 42.50C and 
39.40C during the 6th treatment, respectively. These first clinical experiences prompted us to 
initiate a phase I study to evaluate feasibility, toxicity and quality of life during 
hyperthermia using magnetic nanoparticles in patients with biopsy-proven local recurrence 
of prostate cancer following radiotherapy with curative intent. To the authors’ knowledge, 
this is the first report on clinical application of interstitial hyperthermia using magnetic 
nanoparticles in the treatment of human cancer. 
Akihiko et al have developed a novel hyperthermic treatment modality using magnetic 
materials for metastatic bone tumors. The purpose of this study is to show the results of 
novel hyperthermia for metastatic bone tumors. This novel hyperthermic treatment 
modality was used for 15 patients with 16 metastatic bone lesions. In seven lesions, after 
curettage of the metastatic lesion followed by reinforcement with a metal intra-medullary 
nail or plate, calcium phosphate cement (CPC) containing powdery Fe3O4 was implanted 
into the cavity. In one lesion, prosthetic reconstruction was then performed after an 
intralesional tumor excision. For the remaining eight lesions, metal intra-medullary nails 
were inserted into the affected bone. Hyperthermic therapy was started at 1 week 
postoperatively. To comparatively evaluate the radiographic results of patients who 
underwent hyperthermia (HT group), the authers also assessed eight patients who received 
a palliative operation without either radiotherapy or hyperthermia (Op group), and 22 
patients who received operation in combination with postoperative radiotherapy (Op + RT 
group). In HT group, all patients had an acceptable limb function with pain relief without 
any complications. On radiographs, 87, 38, and 91% were, respectively, considered to 
demonstrate an effective treatment outcome in HT group, Op group, and Op + RT group. 
The patients in HT group showed a statistically better radiographic outcome than the 
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patients in Op group (P = 0.0042). But when compared between HT group and Op + RT 
group, there were no significant difference (P = 0.412). This first series of clinical 
hyperthermia using magnetic materials achieved good local control of metastatic bone 
lesion. 
Study by Manfred et al 2007, or by using laser against gold nanoparticles,  for instance 
Yusheng et al 2009 used core shells (silica as a core with a diameter 110nm and an outer gold 
shell with thickness 15 nm) to mediate laser surgery stimulation for prostate cancer 
treatment. The goal of this paper is to present an integrated computer model using a so-
called nested-block optimization algorithm to simulate laser surgery and provides transient 
temperature field predictions. In particular, this algorithm aims to capture changes in 
optical and thermal properties due to nanoshell inclusion and tissue property variation 
during laser surgery. Numerical results show that this model is able to characterize 
variation of tissue properties for laser surgical procedures and predict transient temperature 
field comparable to that measured by in vivo magnetic resonance temperature imaging 
(MRTI) techniques. Note that the computational approach presented in the study is quite 
general and can be applied to other types of nanoparticle inclusions. 
In conclusion, this is a brief review on different approaches for inducing hyperthermia 
cancer treatment relevant to nanomedicine  
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